BACKGROUND AND AIM: The pathophysiological mechanisms leading to the development of non-alcoholic steatohepatitis (NASH) remain unclear. There are differences in the susceptibility to NASH between the different species and sexes. The investigation of the precise mechanism of interstrain differences may provide new means by which the pathophysiological mechanisms of NASH may be understood. METHODS: C57BL/6N and C3H/HeN mice were administered a methionine- and choline-deficient (MCD) diet to establish a dietary model of NASH. RESULTS: An elevation of the serum alanine aminotransferase and increased infiltration of inflammatory cells were predominant in C57BL/6N mice at 8 weeks. The increase in the steatosis and lipid contents in the liver was greater in C57BL/6N mice than in C3H/HeN mice. The indices of lipid peroxidation demonstrated by F2-isoprostanes or 8-hydroxy-2'-deoxyguanosine also increased in the livers of C57BL/6N mice. Furthermore, Sirius red staining revealed an increase in the degree of fibrosis in C57BL/6N mice given the MCD diet. As a result, the C57BL/6N strain had a higher susceptibility to NASH than the C3H/HeN mice. The carnitine palmitoyltransferase 1A (in beta-oxidation) mRNA and mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase 2 (in ketogenesis) mRNA were downregulated in the C57BL/6N mice in comparison with C3H/HeN mice. There were no differences in the expression of microsomal triglyceride transfer protein or sterol regulatory element binding protein 1 between the C57BL/6N and C3H/HeN mice. CONCLUSION: There were interstrain differences in susceptibility to NASH observed in a rodent dietary model. Further evaluations of the precise molecular mechanism of this interstrain difference may provide some indications of the pathophysiological mechanisms of NASH in humans.
BACKGROUND AND AIM: The pathophysiological mechanisms leading to the development of non-alcoholic steatohepatitis (NASH) remain unclear. There are differences in the susceptibility to NASH between the different species and sexes. The investigation of the precise mechanism of interstrain differences may provide new means by which the pathophysiological mechanisms of NASH may be understood. METHODS: C57BL/6N and C3H/HeN mice were administered a methionine- and choline-deficient (MCD) diet to establish a dietary model of NASH. RESULTS: An elevation of the serum alanine aminotransferase and increased infiltration of inflammatory cells were predominant in C57BL/6N mice at 8 weeks. The increase in the steatosis and lipid contents in the liver was greater in C57BL/6N mice than in C3H/HeN mice. The indices of lipid peroxidation demonstrated by F2-isoprostanes or 8-hydroxy-2'-deoxyguanosine also increased in the livers of C57BL/6N mice. Furthermore, Sirius red staining revealed an increase in the degree of fibrosis in C57BL/6N mice given the MCD diet. As a result, the C57BL/6N strain had a higher susceptibility to NASH than the C3H/HeN mice. The carnitine palmitoyltransferase 1A (in beta-oxidation) mRNA and mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase 2 (in ketogenesis) mRNA were downregulated in the C57BL/6N mice in comparison with C3H/HeN mice. There were no differences in the expression of microsomal triglyceride transfer protein or sterol regulatory element binding protein 1 between the C57BL/6N and C3H/HeN mice. CONCLUSION: There were interstrain differences in susceptibility to NASH observed in a rodent dietary model. Further evaluations of the precise molecular mechanism of this interstrain difference may provide some indications of the pathophysiological mechanisms of NASH in humans.
Authors: Volodymyr Tryndyak; Aline de Conti; Tetyana Kobets; Kristy Kutanzi; Igor Koturbash; Tao Han; James C Fuscoe; John R Latendresse; Stepan Melnyk; Svitlana Shymonyak; Leonard Collins; Sharon A Ross; Ivan Rusyn; Frederick A Beland; Igor P Pogribny Journal: FASEB J Date: 2012-08-07 Impact factor: 5.191
Authors: Angela M Betancourt; Adrienne L King; Jessica L Fetterman; Telisha Millender-Swain; Rachel D Finley; Claudia R Oliva; David R Crowe; Scott W Ballinger; Shannon M Bailey Journal: Biochem J Date: 2014-07-15 Impact factor: 3.857
Authors: Heather B Eccleston; Kelly K Andringa; Angela M Betancourt; Adrienne L King; Sudheer K Mantena; Telisha M Swain; Heather N Tinsley; Ryan N Nolte; Tim R Nagy; Gary A Abrams; Shannon M Bailey Journal: Antioxid Redox Signal Date: 2011-03-31 Impact factor: 8.401
Authors: Igor P Pogribny; Athena Starlard-Davenport; Volodymyr P Tryndyak; Tao Han; Sharon A Ross; Ivan Rusyn; Frederick A Beland Journal: Lab Invest Date: 2010-06-14 Impact factor: 5.662
Authors: Kristen Stephenson; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Joanne Thomson; Gianfranco Alpini; Heather Francis Journal: Gene Expr Date: 2017-11-02
Authors: Yvette Simon; Sonja M Kessler; Katja Gemperlein; Rainer M Bohle; Rolf Müller; Johannes Haybaeck; Alexandra K Kiemer Journal: World J Gastroenterol Date: 2014-12-21 Impact factor: 5.742
Authors: Igor P Pogribny; Volodymyr P Tryndyak; Tetyana V Bagnyukova; Stepan Melnyk; Beverly Montgomery; Sharon A Ross; John R Latendresse; Ivan Rusyn; Frederick A Beland Journal: J Hepatol Date: 2009-05-03 Impact factor: 25.083
Authors: Volodymyr P Tryndyak; John R Latendresse; Beverly Montgomery; Sharon A Ross; Frederick A Beland; Ivan Rusyn; Igor P Pogribny Journal: Toxicol Appl Pharmacol Date: 2012-04-24 Impact factor: 4.219